OSEBX1,423.56+0.84%
EQNR284.60+4.20%
DNB198.35-1.15%
MOWI172.80+0.45%
Brent$71.24-0.32%
EUR/USD1.0824-0.14%
DXY104.18+0.08%
INDICATIVE · SAMPLE DATA
2373$414.0058

Care Twentyone Corp

Healthcare Facilities & ServicesVerified

Care Twentyone Corp has a liquidity position that is characterized by a current ratio of 1.05, indicating a balanced short-term liquidity position. The company's price-to-book ratio is 1.27, suggesting that the market value is slightly above the book value. The company's price-to-earnings ratio is 14.57, which is a measure of how much investors are willing to pay per share for a company's earnings. In terms of profitability, Care Twentyone Corp has a return on equity of 8.69%, which is a measure of the company's profitability relative to shareholders' equity. The return on assets is 1.24%, indicating the efficiency of the company in generating profits from its assets. The debt-to-equity ratio is 4.19, which is relatively high, suggesting that the company is using a significant amount of debt to finance its operations. The company's revenue is primarily derived from nursing care services, with a focus on home care and facility services. The geographic exposure is concentrated in Japan, as the company is based there and operates within the Japanese market. The company's revenue concentration is not disclosed in the provided data, but the focus on domestic operations suggests a high level of exposure to the Japanese market. The growth trajectory of Care Twentyone Corp is reflected in its financial performance. The company's operating income is 433,260,000 JPY, and the net income is 384,176,000 JPY. The company's capital expenditure is -307,515,000 JPY, indicating a reduction in capital spending. The outlook for the company's revenue and profitability is not explicitly provided, but the financial data suggests a stable performance. The risk assessment for Care Twentyone Corp indicates a medium level of liquidity risk and a low level of dilution risk. The company's key flags include a negative net cash position after subtracting total debt, which could impact its liquidity. The dilution potential is low, suggesting that the company is not expected to issue additional shares that would dilute existing shareholders' equity. Recent events related to Care Twentyone Corp include the latest financial data and analyst estimates. The last actual EPS is 28.45 JPY, and the last actual revenue is 48,158,160,000 JPY. These figures provide insight into the company's recent performance and are used by analysts to assess the company's financial health.

30-day price · 2373-24.00 (-5.5%)
Low$404.00High$456.00Close$414.00As of21 May, 00:00 UTC
Profile
CompanyCare Twentyone Corp
Ticker2373.T
SectorHealthcare
BusinessHealthcare Services & Equipment
Industry groupHealthcare Services & Equipment
IndustryHealthcare Facilities & Services
AI analysis

Business. Care Twentyone Corp provides nursing care services in Japan, including home care, care prevention, and facility services for elderly care, medical care, and welfare equipment sales and rentals.

Classification. Care Twentyone Corp is classified under the Healthcare sector, specifically in the Healthcare Facilities & Services industry, with a confidence level of 0.92.

Care Twentyone Corp has a liquidity position that is characterized by a current ratio of 1.05, indicating a balanced short-term liquidity position. The company's price-to-book ratio is 1.27, suggesting that the market value is slightly above the book value. The company's price-to-earnings ratio is 14.57, which is a measure of how much investors are willing to pay per share for a company's earnings. In terms of profitability, Care Twentyone Corp has a return on equity of 8.69%, which is a measure of the company's profitability relative to shareholders' equity. The return on assets is 1.24%, indicating the efficiency of the company in generating profits from its assets. The debt-to-equity ratio is 4.19, which is relatively high, suggesting that the company is using a significant amount of debt to finance its operations. The company's revenue is primarily derived from nursing care services, with a focus on home care and facility services. The geographic exposure is concentrated in Japan, as the company is based there and operates within the Japanese market. The company's revenue concentration is not disclosed in the provided data, but the focus on domestic operations suggests a high level of exposure to the Japanese market. The growth trajectory of Care Twentyone Corp is reflected in its financial performance. The company's operating income is 433,260,000 JPY, and the net income is 384,176,000 JPY. The company's capital expenditure is -307,515,000 JPY, indicating a reduction in capital spending. The outlook for the company's revenue and profitability is not explicitly provided, but the financial data suggests a stable performance. The risk assessment for Care Twentyone Corp indicates a medium level of liquidity risk and a low level of dilution risk. The company's key flags include a negative net cash position after subtracting total debt, which could impact its liquidity. The dilution potential is low, suggesting that the company is not expected to issue additional shares that would dilute existing shareholders' equity. Recent events related to Care Twentyone Corp include the latest financial data and analyst estimates. The last actual EPS is 28.45 JPY, and the last actual revenue is 48,158,160,000 JPY. These figures provide insight into the company's recent performance and are used by analysts to assess the company's financial health.
Key takeaways
  • Care Twentyone Corp has a balanced short-term liquidity position with a current ratio of 1.05.
  • The company's return on equity is 8.69%, indicating a relatively strong profitability relative to shareholders' equity.
  • The company's debt-to-equity ratio is 4.19, suggesting a high level of debt financing.
  • The company's revenue is primarily derived from nursing care services in Japan.
  • The company's liquidity risk is medium, and the dilution risk is low.
  • The company's recent financial performance shows a stable operating income and net income.
  • --
  • # RATIONALES
Financial snapshot
PeriodHA-latest
CurrencyJPY
Revenue$48.16B
Gross profit$11.12B
Operating income$433.3M
Net income$384.2M
R&D
SG&A
D&A
SBC
Operating cash flow$2.15B
CapEx-$307.5M
Free cash flow$1.29B
Total assets$31.03B
Total liabilities$26.61B
Total equity$4.42B
Cash & equivalents$4.17B
Long-term debt$18.55B
Annual history (last 5)
PeriodRevenueOp IncomeNet IncomeFCF
FY0$48.16B$433.3M$384.2M$1.29B
FY-1$45.40B-$626.1M$278.4M$233.3M
FY-2$41.10B-$497.3M$6.2M-$271.3M
FY-3$38.40B$970.7M$630.5M$948.2M
FY-4$36.36B$1.30B$937.1M$919.3M
PeriodGross %Op %Net %FCF %
FY0
FY-1
FY-2
FY-3
FY-4
PeriodAssetsEquityCashDebt
FY0$31.03B$4.42B$4.17B
FY-1$31.67B$4.71B$3.08B
FY-2$31.82B$5.50B$2.61B
FY-3$36.38B$6.46B$1.88B
FY-4$37.60B$6.77B$2.83B
PeriodOCFCapExFCFSBC
FY0$2.15B-$307.5M$1.29B
FY-1$709.9M-$1.21B$233.3M
FY-2$2.14B-$1.66B-$271.3M
FY-3$1.12B-$929.0M$948.2M
FY-4$2.61B-$1.20B$919.3M
Quarterly history (last 4)
PeriodRevenueOp IncomeNet IncomeFCF
FQ0$12.19B$224.1M$62.6M
FQ-1$12.24B$71.9M$157.7M
FQ-2$12.30B$391.9M$260.6M
FQ-3$11.81B-$105.2M$48.8M
FQ-4$11.81B$74.6M-$83.0M
FQ-5$11.79B-$193.2M$378.5M
FQ-6$11.66B$198.5M$370.5M
FQ-7$11.08B-$390.5M-$227.0M
PeriodGross %Op %Net %FCF %
FQ0
FQ-1
FQ-2
FQ-3
FQ-4
FQ-5
FQ-6
FQ-7
PeriodAssetsEquityCashDebt
FQ0$32.43B$4.46B$5.58B
FQ-1$31.03B$4.42B$4.17B
FQ-2$31.33B$4.28B$3.84B
FQ-3$31.23B$4.04B$3.61B
FQ-4$31.32B$4.46B$3.30B
FQ-5$31.67B$4.71B$3.08B
FQ-6$33.31B$4.80B$3.23B
FQ-7$32.19B$4.78B$2.00B
PeriodOCFCapExFCFSBC
FQ0
FQ-1$2.15B-$307.5M
FQ-2
FQ-3$817.3M-$155.3M
FQ-4
FQ-5$709.9M-$1.21B
FQ-6
FQ-7-$18.6M-$927.8M
Valuation
Market price$414.00
Market cap$5.60B
Enterprise value$19.98B
P/E14.6
Reported non-GAAP P/E
EV/Revenue0.4
EV/Op income46.1
EV/OCF9.3
P/B1.3
P/Tangible book1.3
Tangible book$4.42B
Net cash-$14.38B
Current ratio1.1
Debt/Equity4.2
ROA1.2%
ROE8.7%
Cash conversion5.6%
CapEx/Revenue-0.6%
SBC/Revenue
Asset intensity
Dilution ratio0.0%
Risk assessment
Dilution riskLow
Liquidity riskMedium
  • Net cash is negative after subtracting total debt.
Industry benchmarks
Activity: Biotechnology · cohort 9 companies
Metric2373Activity
Op margin0.9%11.5% medp25 9.9% · p75 15.0%bottom quartile
Net margin0.8%8.6% medp25 6.3% · p75 12.4%bottom quartile
Gross margin23.1%28.8% medp25 28.8% · p75 28.8%bottom quartile
CapEx / revenue-0.6%4.2% medp25 3.8% · p75 4.2%bottom quartile
Debt / equity419.0%71.3% medp25 60.7% · p75 71.3%top quartile
Observations
IR observations
Last actual EPS28.45 JPY
Last actual revenue48,158,160,000 JPY
Source data
Underlying data the analysis-pipeline pulls and audits. Fetch timestamps + content hashes show when each source was last refreshed.
Company fundamentalsperiod FQ-7 · history via verified-market-data
no public URL
2026-05-11 01:32 UTC#3abf5531
Market quoteclose JPY 414.00 · shares 0.01B diluted
no public URL
2026-05-11 01:32 UTC#af09df72
Source: analysis-pipeline (hybrid)Generated: 2026-05-11 01:35 UTCJob: 83b23519